Skip to main content

Most Popular Diabetes News

Glucagon is a hormone produced by the pancreas that raises blood sugar levels by prompting the liver to convert stored glycogen into glucose. It is essential for glucose...
Unraveling the link between diabetes and depression, the role of age, and how antidepressants impact diabetes. Discover key management and support tips.
FDA-approved AspyreRx is a digital therapy app for type 2 diabetes that uses CBT to boost wellness and glucose management via smartphone.
Explore diabetes-friendly fast food options at Chipotle Mexican Grill. Get dietitian-approved picks and tips for healthier choices while maintaining your carb budget.
Brenzavvy, an affordable FDA-approved Type 2 diabetes drug, now accessible via Cost Plus Drugs, aids in effective glucose management and diabetes control.
Novo Nordisk's Wegovy cuts heart risk by 20% in people with obesity or overweight and without diabetes. Semaglutide's potential reshapes cardiovascular & obesity...
Explore diabetes-friendly fast food options. Get dietitian-approved picks and tips for healthier choices while maintaining your carb budget.
Discover how a new predictive tool can forecast the risk of chronic kidney disease in type 2 diabetes patients. Learn about its benefits, limitations, and potential for...
Uncover the intricate connection between moods and blood sugar levels. Learn how families can navigate this complex relationship effectively.
Discover the FreeStyle Libre 3 CGM system: now available for Medicare users, featuring real-time glucose readings sent directly to a mobile app or optional handheld...
Lilly’s SURMOUNT-3 and SURMOUNT-4 clinical trials show that Mounjaro (tirzepatide) demonstrates remarkable weight loss in patients with a BMI of more than 30, with...
At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...
Lantidra (donislecel) by Celltrans receives FDA approval as first-ever pancreatic islet beta cell therapy for treatment of type 1 diabetes.
PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.
end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.
FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and...
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
Beta Bionics has received FDA clearance for its insulin-only iLet Bionic Pancreas, an automated insulin delivery system that eliminates the need for carbohydrate...
Explore the understated impact of hyperglycemia fears in diabetic children, the need for enhanced research, and strategies for safe diabetes management.
Learn how to increase access to diabetes tech for children with type 1 diabetes. Healthcare providers discuss how treatments and better access to resources can help...

Pages